Background: Severe or fulminant infection (SFCDI) is associated with significant morbidity and mortality. Emerging evidence suggests fecal microbiota transplant (FMT) may be a promising therapy for SFCDI.
Aim: This systematic review determines the safety and efficacy of FMT in medically refractory SFCDI.